Chlormezanone

CAS No. 80-77-3

Chlormezanone( (±)-Chlormezanone | NSC 169108 )

Catalog No. M16019 CAS No. 80-77-3

Chlormezanone, a non-benzodiazepine that is used in the management of anxiety.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG 37 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Chlormezanone
  • Note
    Research use only, not for human use.
  • Brief Description
    Chlormezanone, a non-benzodiazepine that is used in the management of anxiety.
  • Description
    Chlormezanone, a non-benzodiazepine that is used in the management of anxiety.(In Vivo):Comparative results obtained with Chlormezanone in the dosage levels capable of producing more than 80% depression in the contralateral extensor.
  • In Vitro
    ——
  • In Vivo
    Comparative results obtained with Chlormezanone in the dosage levels capable of producing more than 80% depression in the contralateral extensor.
  • Synonyms
    (±)-Chlormezanone | NSC 169108
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Translocator protein
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    80-77-3
  • Formula Weight
    273.73
  • Molecular Formula
    C11H12ClNO3S
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 26 mg/mL (94.98 mM); DMSO: 55 mg/mL (200.92 mM)
  • SMILES
    CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl
  • Chemical Name
    2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Overington JP, et al. Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
molnova catalog
related products
  • Peonidin-3-O-[6-O-(E...

    Peonidin-3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-O-β-D-glucoside

  • KRA-533

    KRA-533 is a potent KRAS agonist. KRA-533 binds to the GTP/GDP binding pocket in the KRAS protein to prevent GTP cleavage, resulting in the accumulation of constitutively active GTP-bound KRAS that triggers both apoptotic and autophagic cell death pathways in cancer cells.

  • Pomalidomide-PEG4-C2...

    Pomalidomide-PEG4-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate incorporating the Pomalidomide-based cereblon ligand and 4-unit PEG linker.